Literature DB >> 29618505

Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.

Amanda E Calvert1, Karen L Boroughs2, Janeen Laven2, Janae L Stovall2, Betty E Luy2, Olga I Kosoy2, Claire Y-H Huang2.   

Abstract

Zika virus (ZIKV) has emerged as a major global public health concern due to its link as a causative agent of human birth defects. Laboratory diagnosis of suspected ZIKV infections by serological testing of specimens collected a week or more after symptom onset primarily relies on detection of anti-ZIKV-specific IgM antibodies by enzyme-linked immunosorbent assay coupled with detection of ZIKV-specific neutralizing antibody by neutralization tests. A definitive diagnosis based on serological assays is possible during primary ZIKV infections; however, due to the cross-reactivity of antibodies elicited during flaviviral infections, a definitive diagnosis is not always possible, especially among individuals who have previously been exposed to closely related flaviviruses, such as dengue virus (DENV). Here, we investigated the neutralizing IgM antibody profiles of 33 diagnostic specimens collected from individuals with suspected primary and secondary flaviviral infections acquired when visiting areas experiencing active ZIKV transmission in 2015 and 2016. Specimens collected between 1 day and 3 months postexposure were tested for ZIKV and dengue virus type 1 (DENV1) and type 2 (DENV2) by the plaque reduction neutralization test (PRNT) before and after IgG depletion. We found that IgG depletion prior to neutralization testing had little effect in differentiating samples from individuals with secondary infections taken less than 3 weeks postexposure; however, IgG depletion significantly reduced the cross-reactive neutralizing antibody titers and increased the percentage of cases discernible by PRNT from 15.4% (95% confidence interval [CI], 4.3 to 42.2%) to 76.9% (95% CI, 49.7 to 91.8%) for samples collected between roughly 3 and 12 weeks postexposure. These results highlight the potential of IgG depletion to improve the specificity of PRNT for better confirmation and differential diagnosis of flavivirus infections.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Zika virus; confirmatory testing; dengue virus; flavivirus; immunoglobulin M; neutralization test; neutralizing antibodies; serological testing

Mesh:

Substances:

Year:  2018        PMID: 29618505      PMCID: PMC5971560          DOI: 10.1128/JCM.00234-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

3.  Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

Authors:  Wen-Yang Tsai; Anna Durbin; Jih-Jin Tsai; Szu-Chia Hsieh; Stephen Whitehead; Wei-Kung Wang
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

4.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Authors:  Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

5.  Evidence of Sexual Transmission of Zika Virus.

Authors:  Eric D'Ortenzio; Sophie Matheron; Yazdan Yazdanpanah; Xavier de Lamballerie; Bruno Hubert; Géraldine Piorkowski; Marianne Maquart; Diane Descamps; Florence Damond; Isabelle Leparc-Goffart
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

6.  Guillain-Barré syndrome associated with Zika virus infection.

Authors:  Patrícia Brasil; Patricia Carvalho Sequeira; Andrea D'Avila Freitas; Heruza Einsfeld Zogbi; Guilherme Amaral Calvet; Rogerio Valls de Souza; André Machado Siqueira; Marcos Cesar Lima de Mendonca; Rita Maria Ribeiro Nogueira; Ana Maria Bispo de Filippis; Tom Solomon
Journal:  Lancet       Date:  2016-04-02       Impact factor: 79.321

7.  Surveillance of Zika virus infection and microcephaly in Brazil.

Authors:  Jörg Heukelbach; Guilherme Loureiro Werneck
Journal:  Lancet       Date:  2016-06-29       Impact factor: 79.321

8.  An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014.

Authors:  Giulietta Venturi; Lorenzo Zammarchi; Claudia Fortuna; Maria Elena Remoli; Eleonora Benedetti; Cristiano Fiorentini; Michele Trotta; Caterina Rizzo; Antonia Mantella; Giovanni Rezza; Alessandro Bartoloni
Journal:  Euro Surveill       Date:  2016

9.  Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses.

Authors:  E G Westaway
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

10.  Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014.

Authors:  D Musso; T Nhan; E Robin; C Roche; D Bierlaire; K Zisou; A Shan Yan; V M Cao-Lormeau; J Broult
Journal:  Euro Surveill       Date:  2014-04-10
View more
  5 in total

1.  Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice.

Authors:  Whitney R Baldwin; Jill A Livengood; Holli A Giebler; Janae L Stovall; Karen L Boroughs; Stephanie Sonnberg; Kelly J Bohning; Elizabeth A Dietrich; Yee Tsuey Ong; Hoang K Danh; Hetal K Patel; Claire Y-H Huang; Hansi J Dean
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

2.  The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.

Authors:  Amanda E Calvert; Kalanthe Horiuchi; Karen L Boroughs; Yee T Ong; Kimberly M Anderson; Brad J Biggerstaff; Mars Stone; Graham Simmons; Michael P Busch; Claire Y-H Huang
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

3.  Comparative specificity and sensitivity of NS1-based serological assays for the detection of flavivirus immune response.

Authors:  Erick Mora-Cárdenas; Chiara Aloise; Valentina Faoro; Nataša Knap Gašper; Miša Korva; Ilaria Caracciolo; Pierlanfranco D'Agaro; Tatjana Avšič-Županc; Alessandro Marcello
Journal:  PLoS Negl Trop Dis       Date:  2020-01-29

4.  A need to raise the bar - A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research.

Authors:  Tehmina Bharucha; Freya M Shearer; Manivanh Vongsouvath; Mayfong Mayxay; Xavier de Lamballerie; Paul N Newton; Nicole Zitzmann; Ernest Gould; Audrey Dubot-Pérès
Journal:  Int J Infect Dis       Date:  2020-03-20       Impact factor: 3.623

Review 5.  Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care.

Authors:  Md Alamgir Kabir; Hussein Zilouchian; Muhammad Awais Younas; Waseem Asghar
Journal:  Biosensors (Basel)       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.